ELI LILLY AND COMPANY
ELI LILLY AND COMPANY
ELI LILLY AND COMPANY
SK
At a glance
Works on
Background
Career
EL
WASHINGTON, DC · current
Government experience
Legislative Asst
Senator Bayh
Covered official positions, as disclosed on federal filings
The past 12 months
Clients
1
past 12 months
Filings
3
past 12 months
Agencies contacted
Commerce, Dept of (DOC)Executive Office of the President (EOP)Food & Drug Administration (FDA)HOUSE OF REPRESENTATIVESHealth & Human Services, Dept of (HHS)SENATEState, Dept of (DOS)U.S. Trade Representative (USTR)
Specific issues
Hospital discounts; 340B program; Prescription drug value, access, quality and compliance with Drug Quality and Safety Act
Implementation and extension of the Tax Cuts and Jobs Act; Domestic manufacturing tax incentives; Expensing of research and development costs; Global minimum tax; Pension and retirement benefit issues; round-tripping
Intellectual property; 340B Program; Medicare & Medicaid prescription drug diagnosis and screening reimbursement pricing, coverage, value and access; Implementation of the "Inflation Reduction Act" (HR.5376); CMS National Coverage Determination on Alzheimer's disease
Issues related to intellectual property protection and market access within current trade negotiations. Canada IP; USMCA implementation; Mexico patent linkage; Special 301; Trade talks: US-Japan, US-China, US-EU, US-UK, US-India, and US-Brazil; US Tariffs
Multi-lateral threats to IP and the biopharmaceutical industry; Drug importation; Prescription drug value, access and quality
Patient protection; Pharmaceutical supply chain issues and shortages; Drug pricing, coverage, value, access and quality; Transparency; Intellectual property; Health insurance accessibility; Implementation of the "Inflation Reduction Act" (HR.5376); Prescription drug approval; Policy matters related to Artificial Intelligence in health care
Clients
Sources
This profile is built from the public record: filings in the U.S. Senate Lobbying Disclosure Act system. lda.senate.gov ↗